News

Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus challenges when combined with a mucosal adjuvant, according to a study.

A potential treatment for glioblastoma crafted by scientists at The Wertheim UF Scripps Institute renders the deadly brain cancer newly sensitive to both radiation and chemotherapy drugs, and blocks the cancer’s ability to invade other tissues.

There is a perception that common drugs such as ibuprofen and SSRI preparations can trigger the intestinal disease microscopic colitis. However, a new study from Karolinska Institutet and Harvard Medical School suggests that this is not the case.

Researchers have introduced a mouse motion capture method that provides very high-resolution measurement of mouse movement. Their marker-based approach avoids the need for extensive data processing with AI or machine learning.

In a large clinical trial, pramipexole was found to be substantially more effective than a placebo at reducing the symptoms of treatment resistant depression over the course of nearly a year.

Nearly half of all patients with anxiety or depression experience no effect from the drugs they are first prescribed. Research shows that our genes may predict which drugs work, potentially allowing doctors to choose the right drug on the first try.

A recent study reveals that slowing down the intracellular transport of RNA-based drugs can significantly enhance their effectiveness. These therapeutics are currently used to treat rare genetic diseases.

Water molecules represent a powerful but largely underappreciated foothold in drug binding studies. See how ColdBrew can provide accurate water displacement predictions for protein structures, providing a clearer landscape for drug discovery.

Findings from three patients in a gene therapy clinical trial showed that gene therapy treatment significantly improved blood flow in the brain. These results demonstrate that people with associated risk factors should be considered for trials.

Researchers have used magnetoencephalography brain imaging technology to determine how the drug levodopa, the main drug used in dopamine replacement therapy, affects signals in the brain.